Major response to immunotherapy in early-stage mismatch repair deficient colon cancer
byEuropean Society for Medical OncologyCredit:Annals of OncologyPre-operative treatment with a combination of the immune checkpoint inhibitors nivolumab and ipilimumab achieves major patho
Updated on: December 18,2023
11
Major response to immunotherapy in early-stage mismatch repair deficient colon cancer
byEuropean Society for Medical OncologyCredit:Annals of OncologyPre-operative treatment with a combination of the immune checkpoint inhibitors nivolumab and ipilimumab achieves major patho
Updated on:December 18,2023
11